MX342712B - Macromolecula para el suministro de farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma, y una composicion de liberacion lenta para farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma. - Google Patents

Macromolecula para el suministro de farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma, y una composicion de liberacion lenta para farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma.

Info

Publication number
MX342712B
MX342712B MX2012007603A MX2012007603A MX342712B MX 342712 B MX342712 B MX 342712B MX 2012007603 A MX2012007603 A MX 2012007603A MX 2012007603 A MX2012007603 A MX 2012007603A MX 342712 B MX342712 B MX 342712B
Authority
MX
Mexico
Prior art keywords
same
polypeptide
production method
protein
peptide drugs
Prior art date
Application number
MX2012007603A
Other languages
English (en)
Other versions
MX2012007603A (es
Inventor
Woong Yi Yil
Hyo Seo Min
Oh Kim Bong
Ja Choi In
Jeong Yoon Hye
Yoon Kim Se
Jun Lee Sang
Woong Cho Joong
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of MX2012007603A publication Critical patent/MX2012007603A/es
Publication of MX342712B publication Critical patent/MX342712B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/465—Preparation of carboxylic acid esters by oligomerisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/68—Lactic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
    • C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
    • C08J3/215—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase at least one additive being also premixed with a liquid phase
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una macromolécula para suministrar fármacos de proteína, polipéptido o péptido y a un método de producción para la misma, así como también a una composición de liberación lenta para fármacos de proteína, polipéptido o péptido que comprende la misma, y más específicamente se relaciona a un compuesto derivado de ácido poliláctico de la fórmula química 1 de la cual el peso molecular promedio en número no es más que 7,000 daltons y a un. Método de producción para el mismo, así como a una composición de liberación lenta para fármacos de proteína, polipéptido péptido que utilizan el mismo y a un método de producción para el mismo.
MX2012007603A 2009-12-29 2010-12-28 Macromolecula para el suministro de farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma, y una composicion de liberacion lenta para farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma. MX342712B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090132861 2009-12-29
PCT/KR2010/009421 WO2011081406A2 (ko) 2009-12-29 2010-12-28 단백질, 폴리펩타이드 또는 펩타이드 약물 전달용 고분자 및 그 제조방법, 및 단백질, 폴리펩타이드 또는 펩타이드 약물의 서방형 조성물 및 그 제조 방법

Publications (2)

Publication Number Publication Date
MX2012007603A MX2012007603A (es) 2012-08-01
MX342712B true MX342712B (es) 2016-10-10

Family

ID=44227011

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007603A MX342712B (es) 2009-12-29 2010-12-28 Macromolecula para el suministro de farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma, y una composicion de liberacion lenta para farmacos de proteina, polipeptido o peptido y un metodo de produccion para la misma.

Country Status (12)

Country Link
US (1) US9603931B2 (es)
EP (1) EP2520600B1 (es)
JP (1) JP5597724B2 (es)
KR (1) KR101224004B1 (es)
CN (1) CN102741317B (es)
AU (1) AU2010339080B2 (es)
BR (1) BR112012015977B1 (es)
CA (1) CA2784990C (es)
ES (1) ES2628137T3 (es)
MX (1) MX342712B (es)
NZ (1) NZ600775A (es)
WO (1) WO2011081406A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101424163B1 (ko) * 2010-12-24 2014-08-01 주식회사 삼양바이오팜 수난용성 약물 함유 서방성 마이크로입자 및 그 제조방법
KR101467275B1 (ko) * 2011-12-19 2014-12-02 주식회사 삼양바이오팜 분산성이 향상된 생분해성 고분자 미립자의 조성물 및 그 제조방법
KR101547634B1 (ko) 2013-06-21 2015-08-26 가톨릭대학교 산학협력단 약물 전달용 환원성 폴리뉴클레오타이드 고분자 및 이의 제조방법
JP6139029B2 (ja) * 2013-06-21 2017-05-31 ザ カトリック ユニバーシティ オブ コリア インダストリー−アカデミック コーオペレイション ファウンデーション 薬物送達用還元性または非還元性ポリヌクレオチド高分子及びその製造方法
KR101547633B1 (ko) 2013-06-21 2015-08-26 가톨릭대학교 산학협력단 약물 전달용 비환원성 폴리뉴클레오타이드 고분자 및 이의 제조방법
ZA201407536B (en) * 2013-10-21 2017-09-27 Ems Sa Parenteral pharmaceutical composition containing cosyntropin
JP6637484B2 (ja) * 2014-08-07 2020-01-29 ザ ジェネラル ホスピタル コーポレイション 血小板を標的とするマイクロ流体細胞単離
US10160896B2 (en) 2015-04-27 2018-12-25 Halliburton Energy Services, Inc. Delayed-release additives in a degradable matrix
KR101547636B1 (ko) 2015-07-20 2015-08-27 가톨릭대학교 산학협력단 환원성 폴리뉴클레오타이드 고분자를 포함하는 비바이러스성 약물전달용 조성물
KR101547635B1 (ko) 2015-07-20 2015-08-27 가톨릭대학교 산학협력단 비환원성 폴리뉴클레오타이드 고분자를 포함하는 비바이러스성 약물전달용 조성물
CN108660614B (zh) * 2018-05-22 2020-04-03 西南交通大学 一种聚乳酸多孔薄膜及其制备方法
EP4442728A1 (en) * 2021-11-30 2024-10-09 Nisshinbo Holdings Inc. Marine biodegradable polymer compound, marine biodegradation promoter, and marine biodegradable resin composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556559A (es) * 1956-04-13
JPS62135521A (ja) * 1985-12-10 1987-06-18 Daicel Chem Ind Ltd 末端にカルボキシル基を有するポリカプロラクトン
JPS6369825A (ja) * 1986-09-11 1988-03-29 Mitsui Toatsu Chem Inc ブロツク共重合体及びその製造方法
US5196502A (en) * 1991-11-05 1993-03-23 Eastman Kodak Company Method for the preparation of multiply-branched aromatic polyesters
HU220137B (hu) 1993-01-06 2001-11-28 Kinerton Ltd. Biológiailag lebontható poliészterek és biológiailag aktív polipeptidek ionos molekuláris konjugátumai, eljárás ezek előállítására és eljárás mikrorészecskék előállítására
US6221958B1 (en) * 1993-01-06 2001-04-24 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
JP3287425B2 (ja) * 1993-02-04 2002-06-04 東洋紡績株式会社 水酸基末端をエステル封鎖したポリ乳酸およびその製造法
KR0141431B1 (ko) 1994-05-17 1998-07-01 김상웅 생분해성 하이드로겔 고분자
JPH0859642A (ja) 1994-08-22 1996-03-05 Mitsubishi Chem Corp ３，４−アルキレン−１，３，４−チアジアゾリジン−２−オン類の製造方法
US5668288A (en) 1996-04-16 1997-09-16 Depuy Orthopaedics, Inc. Polyester ionomers for implant fabrication
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DK0946169T3 (da) * 1996-12-20 2003-04-22 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af et præparat med vedvarende frigivelse
JPH1121343A (ja) * 1997-07-01 1999-01-26 Mitsui Chem Inc ポリヒドロキシカルボン酸の製造方法
JPH1160928A (ja) * 1997-08-27 1999-03-05 Nishikawa Rubber Co Ltd ポリヒドロキシカルボン酸樹脂組成物およびその製造方法
US6541033B1 (en) 1998-06-30 2003-04-01 Amgen Inc. Thermosensitive biodegradable hydrogels for sustained delivery of leptin
EP1448707B1 (en) * 2001-10-18 2007-08-22 Samyang Corporation Polymeric micelle composition with improved stability
JP2005505675A (ja) 2001-10-18 2005-02-24 サムヤン コーポレイション 高分子ミセルを形成するｐＨ応答性生分解性ポリ乳酸誘導体及び難溶性薬物伝達体への当該誘導体の使用
US20080260850A1 (en) * 2004-05-06 2008-10-23 Samyang Corporation Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative
US7655735B2 (en) * 2004-08-02 2010-02-02 Samyang Corporation Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same
EP1647567A1 (en) * 2004-10-15 2006-04-19 SOLVAY (Société Anonyme) Methods of producing amine-terminated caprolactone polymers and uses of the produced polymers
CN101104706A (zh) * 2007-08-06 2008-01-16 四川大学 聚乳酸及其衍生物的电子束辐射改性方法
KR101024742B1 (ko) 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법

Also Published As

Publication number Publication date
WO2011081406A2 (ko) 2011-07-07
ES2628137T3 (es) 2017-08-01
US20130274188A1 (en) 2013-10-17
JP5597724B2 (ja) 2014-10-01
MX2012007603A (es) 2012-08-01
BR112012015977B1 (pt) 2020-10-06
US9603931B2 (en) 2017-03-28
EP2520600A2 (en) 2012-11-07
EP2520600A4 (en) 2014-01-08
AU2010339080A1 (en) 2012-07-19
AU2010339080B2 (en) 2015-09-17
NZ600775A (en) 2015-01-30
AU2010339080A9 (en) 2015-09-17
EP2520600B1 (en) 2017-03-29
BR112012015977A2 (pt) 2018-05-29
CA2784990C (en) 2015-03-31
CN102741317B (zh) 2015-01-07
KR20110076783A (ko) 2011-07-06
KR101224004B1 (ko) 2013-01-22
CA2784990A1 (en) 2011-07-07
WO2011081406A3 (ko) 2011-12-01
CN102741317A (zh) 2012-10-17
JP2013515833A (ja) 2013-05-09

Similar Documents

Publication Publication Date Title
NZ600775A (en) Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same
AU2016219654A1 (en) Crystallization method and bioavailability
WO2009087082A3 (de) Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
MY150596A (en) Hsp90 inhibitors
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
TW200745003A (en) Novel compounds
EP2185197A4 (en) NOVEL COMPOSITIONS OF A SOLUTION CONTAINING A CELLULAR FACTOR
EA201290482A1 (ru) Стабильные составы для лиофилизации терапевтических частиц
EP2536736A4 (en) PREPARATION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATE PRODUCTS THEREOF
WO2011157722A3 (en) Solid ivabradine-containing composition
IN2012DN01330A (es)
TW200621690A (en) Novel compounds
TN2012000248A1 (en) Novel spiropiperidine compounds
MX2011007978A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MY151005A (en) Amide compounds as boosters of antivirals
WO2009118754A3 (en) A process for preparing a stable lyophilized composition
MX2010003213A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2009000768A (es) Lactamas macrociclicas.
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
WO2010079045A3 (en) Crystalline salt forms of flibanserine
TW200740729A (en) Methods for preparing glutamic acid derivatives
UA103996C2 (en) Ivabradine hydrobromide
SI2247573T1 (sl) Soli ogljikove in Ĺľveplove kisline in 3-(2,2,2-trimetilhidrazin) propionat estrov ter njihova uporaba pri pripravi 3-(2,2,2-trimetilhidrazin) propionat dihidrata
NZ609596A (en) Cyclohexane derivative compound

Legal Events

Date Code Title Description
FG Grant or registration